Collecting samples from lung cancer patients
Specimen Banking From Patients With Lung Cancer
This study is collecting samples from lung cancer patients to help researchers learn more about the disease and find better ways to detect and treat it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Trial ID | NCT01585675 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive specimen banking program for patients diagnosed with lung cancer. By collecting biological samples, the researchers hope to advance the understanding of lung cancer biology, identify early detection markers, and develop better therapeutic strategies. The program will also explore potential screening and prevention methods, ultimately contributing to improved patient outcomes. The study is observational and focuses on gathering data without specific interventions.
Who should consider this trial
Good fit: Ideal candidates are individuals undergoing testing for the diagnosis or treatment of lung cancer who can provide informed consent.
Not a fit: Patients who do not provide consent for participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to earlier detection and more effective treatments for lung cancer patients.
How similar studies have performed: Other studies focusing on specimen banking and biological sample collection have shown promise in advancing cancer research, indicating that this approach is both valuable and tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer. 2. Oral and written informed consent Exclusion Criteria: 1\. Any individual who does not give oral and written consent for participation
Where this trial is running
Aurora, Colorado
- University of Colorado Cancer Center — Aurora, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Adriaan VanBokhoven, PhD — University of Colorado, Denver
- Study coordinator: Brandi Kubala
- Email: brandi.kubala@cuanschutz.edu
- Phone: 303-724-1657
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.